Shares of gold loan companies slip as the metal dips below $4,000 per ounce

CHENNAI: Shares of gold financing companies Manappuram Finance and Muthoot Finance fell up to 3.5 percent on Friday, reflecting a decline in global gold prices below the $4,000 per ounce mark. Manappuram’s stock traded at Rs 284, while Muthoot’s shares slipped to Rs 2,773 in early trade.

Gold prices, which had previously surged to record levels amid geopolitical tensions, strong central bank buying, and expectations of US interest rate cuts, have recently corrected. This pullback has put pressure on gold-backed financial institutions, as gold loan portfolios are closely tied to the metal’s market value.

Both Manappuram and Muthoot generate a large portion of their revenue from gold-backed loans. A decline in gold prices can affect the valuation of their collateral, the quality of their loan book, and overall investor sentiment, leading to short-term volatility in their share prices.

Market analysts, as quoted in reports, say that while the recent dip in gold prices poses immediate challenges for these companies, the long-term prospects remain stable, provided gold prices stabilise and macroeconomic conditions remain supportive. Investors are advised to track global gold trends and economic indicators closely to gauge potential impacts on the sector.

On Friday, gold prices in India saw a decline across all purities. The price of 24-karat gold fell to Rs 12,229 per gram, down Rs 186 from the previous day. Similarly, 22-karat gold dropped to Rs 11,210 per gram, while 18-karat gold was priced at Rs 9,172 per gram, marking a fall of Rs 139.

Internationally, spot gold slipped to $3,976.65 per ounce, down 1.6 percent from the previous session. The decline was driven by profit-taking following a strong rally in recent days, along with a modest rebound in US equities, which reduced demand for safe-haven assets like gold.

Despite the short-term dip, gold has recorded a gain of nearly 9.4 percent over the past month, supported by geopolitical tensions, a weakening US dollar, and consistent central bank buying. Analysts suggest the recent fall represents a consolidation phase after sustained gains, rather than a reversal of the broader uptrend.

In India, the price correction comes ahead of the festive season, which usually boosts demand for gold. The adjustment may influence both consumer purchases and the performance of gold-backed financial instruments. Therefore, market researchers advise investors to closely monitor global economic developments and gold market trends, as further fluctuations can significantly impact both investment and retail buying decisions.

Latest

HCLTech, TCS, Infosys: Why are IT stocks falling again?

Fresh pressure on IT shares as demand concerns and foreign selling unsettle investors

Dr Reddy’s jumps nearly 7% as Sensex falls: Why is the pharma stock rising?

Shares of Dr Reddy’s Laboratories surged sharply on Thursday, bucking a weak broader market and emerging as one of the top gainers on the Nifty 50.

Sensex tumbles 650 points: Why is the stock market falling?

Stock markets remained sharply lower in early trade on Thursday as crude oil above $100, global uncertainty and broad-based selling in financial and IT stocks w

Sensex, Nifty sink as crude oil prices reach $100; IndiGo down 2%

The S&P BSE Sensex was down by 625.09 points to 77,891.40, while the NSE Nifty50 lost 173.90 points to 24,204.20 as of 9:26 am. 

Groww shares hit 52-week high: What’s driving the rally and should you buy now?

Groww shares soar to new heights, but brokerages offer mixed advice

Topics

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Watch out Apple and Samsung, OpenAI is making AI smartphone with agentic capabilities

OpenAI is reportedly working with MediaTek and Qualcomm on smartphone processors, aiming to build an AI-first device powered by agent-led experiences.

ICSE, ISC board results to be out this week? Here’s what CISCE official has to say

The Council for the Indian School Certificate Examinations (CISCE) will declare the much-awaited ICSE Class 10 and ISC Class 12 Results 2026 shortly. Officials

Sam Altman says Codex is causing major FOMO so he changing his sleep schedule

Sam Altman says GPT-5.5 in Codex is so good he’s cutting sleep. He has said due to AI he has switched to polyphasic sleep — a schedule involving multiple sh

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

30 students suspended at Hansraj College over fest chaos, DUSU calls it undemocratic

Hansraj College has placed around 30 students, including four elected union office-bearers, under interim suspension over alleged misconduct tied to its annual

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest
spot_img

Related Articles

Popular Categories

spot_imgspot_img